Redx Pharma PLC - Macclesfield, England-based drug discovery and development focused on cancer and fibrosis - Hires Peter Collum as chief financial officer, starting immediately and based in the New York area. Collum joins from Pharnext SA, a clinical biopharmaceutical firm where he has been CFO & chief business officer since July 2019. Prior to Pharnext, Collum spent more than 17 years in healthcare investment banking, most recently as a partner at boutique investment bank MTS Health Partners.
Collum replaces James Mead as CFO. Mead is moving to chief operations officer at Redx, based at the company's laboratories and head office in Alderley Park, Cheshire.
Current stock price: 62.30 pence
Year-to-date change: down 0.3%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
